Form 8-K - Current report:
SEC Accession No. 0000950170-25-082697
Filing Date
2025-06-06
Accepted
2025-06-06 07:59:29
Documents
10
Period of Report
2025-06-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K mbx-20250605.htm   iXBRL 8-K 59863
  Complete submission text file 0000950170-25-082697.txt   173259

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mbx-20250605.xsd EX-101.SCH 26956
12 EXTRACTED XBRL INSTANCE DOCUMENT mbx-20250605_htm.xml XML 5116
Mailing Address 11711 N. MERIDIAN STREET SUITE 300 CARMEL IN 46032
Business Address 11711 N. MERIDIAN STREET SUITE 300 CARMEL IN 46032 3179893100
MBX Biosciences, Inc. (Filer) CIK: 0001776111 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42272 | Film No.: 251028911
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)